CLINICAL_TRIALS
trial_result
· 2024-10-29
Clinical Trial Update: A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain [Phase 3]
Summary
A Phase 3 trial evaluating linzagolix for endometriosis-associated pain was terminated, with results posted on 2024-10-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 3 | Status: TERMINATED | Results posted: 2024-10-29